As of Jun 24
| +0.13 / +3.36%|
The 4 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 10.00, with a high estimate of 18.00 and a low estimate of 6.00. The median estimate represents a +150.00% increase from the last price of 4.00.
The current consensus among 4 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.